| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Rheumatology 2001; 40: 1066-1068
© 2001 British Society for Rheumatology
Letters to the Editor |
Ocular involvement in Wegener's granulomatosis responding to intravenous cyclophosphamide
1 Rheumatology Unit, Ophthalmology Service and
2 Nephrology Service, Hospital Txagorritxu, Osakidetza, Vitoria, Spain
SIR, Wegener's granulomatosis (WG) is a systemic vasculitis of the upper and lower respiratory tracts together with glomerulonephritis. In addition, variable degrees of disseminated vasculitis, involving both small arteries and veins, may occur [1, 2]. Eye involvement is frequent and may range from a mild conjunctivitis to dacryocystitis, episcleritis, scleritis, granulomatous sclerouveitis, ciliary vessel vasculitis and retro-orbital mass lesions. Retinal vasculitis is described rarely [3]. Failure of antineutrophil cytoplasmic antibody (c-ANCA) titres to revert to normal levels may be associated with the potential for relapse in patients with ocular manifestations of Wegener's granulomatosis [4]. We present the
Notes
References